BRPI0818310A2 - glicerídeos e ácidos graxos de cadeia média como agentes nefroprotetores - Google Patents

glicerídeos e ácidos graxos de cadeia média como agentes nefroprotetores

Info

Publication number
BRPI0818310A2
BRPI0818310A2 BRPI0818310A BRPI0818310A BRPI0818310A2 BR PI0818310 A2 BRPI0818310 A2 BR PI0818310A2 BR PI0818310 A BRPI0818310 A BR PI0818310A BR PI0818310 A BRPI0818310 A BR PI0818310A BR PI0818310 A2 BRPI0818310 A2 BR PI0818310A2
Authority
BR
Brazil
Prior art keywords
glycerides
fatty acids
chain fatty
medium chain
nephroprotective
Prior art date
Application number
BRPI0818310A
Other languages
English (en)
Inventor
Leblond Francois
Gagnon Lyne
Lagraoui Mouna
Pichette Vincent
Original Assignee
Prometic Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prometic Biosciences Inc filed Critical Prometic Biosciences Inc
Publication of BRPI0818310A2 publication Critical patent/BRPI0818310A2/pt
Publication of BRPI0818310A8 publication Critical patent/BRPI0818310A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BRPI0818310A 2007-11-02 2008-11-03 Glicerídeos e ácidos graxos de cadeia média como agentes nefroprotetores BRPI0818310A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98509407P 2007-11-02 2007-11-02
PCT/CA2008/001930 WO2009055933A1 (en) 2007-11-02 2008-11-03 Medium-chain length fatty acids and glycerides as nephroprotection agents

Publications (2)

Publication Number Publication Date
BRPI0818310A2 true BRPI0818310A2 (pt) 2017-10-10
BRPI0818310A8 BRPI0818310A8 (pt) 2017-12-26

Family

ID=40590499

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0818310A BRPI0818310A8 (pt) 2007-11-02 2008-11-03 Glicerídeos e ácidos graxos de cadeia média como agentes nefroprotetores

Country Status (19)

Country Link
US (1) US9532962B2 (pt)
EP (1) EP2299998B1 (pt)
JP (1) JP5575655B2 (pt)
KR (1) KR101601987B1 (pt)
CN (1) CN101878028A (pt)
AU (1) AU2008318196B2 (pt)
BR (1) BRPI0818310A8 (pt)
CA (1) CA2704286C (pt)
DK (1) DK2299998T3 (pt)
ES (1) ES2664594T3 (pt)
IL (1) IL205362A (pt)
MX (1) MX338513B (pt)
MY (1) MY151439A (pt)
NO (1) NO2299998T3 (pt)
NZ (1) NZ584981A (pt)
PT (1) PT2299998T (pt)
RU (1) RU2519215C2 (pt)
WO (1) WO2009055933A1 (pt)
ZA (1) ZA201003030B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120024696A (ko) 2009-05-04 2012-03-14 프로메틱 바이오사이언시즈 인코포레이티드 치환된 방향족 화합물 및 그의 약학적 용도
JP5706142B2 (ja) * 2010-04-28 2015-04-22 株式会社ファンケル フユボダイジュ花のエタノール抽出物を有効成分とする血中グルコース低下剤、内臓脂肪蓄積抑制剤、ｔｇ低下剤、糞中脂肪排泄促進剤
NZ610851A (en) * 2010-10-27 2015-05-29 Prometic Biosciences Inc Compounds and compositions for the treatment of cancer
EP2749281B1 (en) * 2011-08-26 2018-03-28 Osaka University Prophylactic and/or therapeutic agent for cardiovascular complications of diabetes
KR20130023583A (ko) * 2011-08-29 2013-03-08 아주대학교산학협력단 파골세포 형성 억제 효과가 있는 카프르산 및 이를 포함하는 약학적 조성물
WO2015069215A1 (en) 2013-11-05 2015-05-14 Hill's Pet Nutrition, Inc. Methods and compositions for improving kidney function
WO2017074266A1 (en) * 2015-10-30 2017-05-04 National University Of Singapore Androgen biosynthesis inhibitor
CN105559071A (zh) * 2016-01-12 2016-05-11 刘保惠 一种适用于肾病的特殊医学用途配方食品及其制备方法
JP2017214342A (ja) * 2016-06-02 2017-12-07 日清オイリオグループ株式会社 排尿障害の予防用又は改善用組成物
MX2018015188A (es) 2016-06-08 2019-08-21 Sunregen Healthcare Ag Lipidos con un numero impar de atomos de carbono y su uso como una composicion farmaceutica o como un suplemento nutricional.
KR20190102011A (ko) * 2016-12-21 2019-09-02 프로메틱 파마 에스엠티 리미티드 상피-중간엽 전이를 예방 또는 최소화하는 방법 및 조성물
WO2019082912A1 (ja) * 2017-10-27 2019-05-02 学校法人北里研究所 慢性腎臓病の予防又は治療剤
WO2019155336A1 (en) * 2018-02-08 2019-08-15 Societe Des Produits Nestle S.A. Mct-based nutrition blend for providing health benefits in companion animals
MX2021003750A (es) 2018-10-11 2021-06-15 Basf As Compuestos aromaticos y usos farmaceuticos de los mismos.
CN109602012A (zh) * 2018-12-11 2019-04-12 李卫平 一种功能性低蛋白能量米及其制备方法
CN111184728B (zh) * 2020-02-20 2023-04-04 上海市儿童医院 海藻糖在肾病综合征中的应用
EP4539686A1 (en) * 2022-06-15 2025-04-23 Hill's Pet Nutrition, Inc. Pet food compositions
CN118592613B (zh) * 2024-08-05 2025-01-07 杭州康源食品科技有限公司 中链脂肪酸混合结构脂在改善膳食诱导的糖脂代谢紊乱中的应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4602040A (en) 1983-04-18 1986-07-22 Warner-Lambert Company Meclofenamic acid topical pharmaceutical composition
US4737384A (en) * 1985-11-01 1988-04-12 Allied Corporation Deposition of thin films using supercritical fluids
AU651758B2 (en) 1992-02-07 1994-07-28 Tsumura & Co. Side-effect alleviant
US6689700B1 (en) * 1999-11-02 2004-02-10 University Of Massachusetts Chemical fluid deposition method for the formation of metal and metal alloy films on patterned and unpatterned substrates
JP5259905B2 (ja) 2000-06-20 2013-08-07 エヌ・ブイ・ニュートリション・サイエンシス 抗菌剤として適用可能な中鎖脂肪酸
IL142535A0 (en) * 2001-04-11 2002-03-10 Yeda Res & Dev Pharmaceutical compositions for the treatment of inflammation
PT1385498E (pt) * 2001-04-18 2007-12-14 Prometic Biosciences Inc Ácidos gordos como factores de sobrevivência e activação de neutrófilos
CN1827766B (zh) 2001-06-28 2010-08-25 徐荣祥 体外细胞的培养方法
RU2213570C2 (ru) * 2001-08-22 2003-10-10 Санкт-Петербургская Государственная Химико-Фармацевтическая Академия ЛЕЧЕБНО-ПРОФИЛАКТИЧЕСКОЕ СРЕДСТВО ИЗ ЛИСТЬЕВ ЛИПЫ Folia Tilia И СПОСОБ ПОЛУЧЕНИЯ ЭКСТРАКТИВНЫХ ВЕЩЕСТВ
US7030168B2 (en) * 2001-12-31 2006-04-18 Advanced Technology Materials, Inc. Supercritical fluid-assisted deposition of materials on semiconductor substrates
US20040052836A1 (en) 2002-09-13 2004-03-18 Li Luk Chiu Pharmaceutical compositions containing at least one stable liposphere having an improved shelf life
BRPI0407276A (pt) * 2003-02-07 2006-01-31 Prometic Biosciences Inc ácidos graxos, glicerìdeos e análogos com comprimento de cadeia médio, como estimulantes de eritropoiese
SI1648851T1 (sl) 2003-07-25 2007-10-31 Prometic Biosciences Inc Priprava kovinskih soli maščobnih kislin s srednjo verigo
EP1940379A4 (en) 2005-09-30 2009-05-13 Jackson H M Found Military Med METHOD FOR THE TREATMENT OF HEMORRHAGIC SHOCKS AND ASSOCIATED DISEASES

Also Published As

Publication number Publication date
ES2664594T3 (es) 2018-04-20
MY151439A (en) 2014-05-30
EP2299998B1 (en) 2018-01-03
JP2011502174A (ja) 2011-01-20
NZ584981A (en) 2012-05-25
US9532962B2 (en) 2017-01-03
KR101601987B1 (ko) 2016-03-09
PT2299998T (pt) 2018-04-02
EP2299998A1 (en) 2011-03-30
CA2704286C (en) 2016-08-23
CN101878028A (zh) 2010-11-03
BRPI0818310A8 (pt) 2017-12-26
IL205362A0 (en) 2010-12-30
IL205362A (en) 2015-01-29
AU2008318196A1 (en) 2009-05-07
MX2010004856A (es) 2010-06-30
WO2009055933A1 (en) 2009-05-07
RU2010122302A (ru) 2011-12-10
ZA201003030B (en) 2011-02-23
DK2299998T3 (en) 2018-03-26
RU2519215C2 (ru) 2014-06-10
US20100286269A1 (en) 2010-11-11
NO2299998T3 (pt) 2018-06-02
EP2299998A4 (en) 2011-03-30
AU2008318196B2 (en) 2014-04-10
KR20100106958A (ko) 2010-10-04
CA2704286A1 (en) 2009-05-07
JP5575655B2 (ja) 2014-08-20
MX338513B (es) 2016-04-20

Similar Documents

Publication Publication Date Title
BRPI0818310A2 (pt) glicerídeos e ácidos graxos de cadeia média como agentes nefroprotetores
BRPI0921467A8 (pt) enzimas e métodos para produzir ácidos graxos ômega-3
LT2315740T (lt) Acetilinti riebalų rūgščių salicilatai ir jų panaudojimas
BRPI0814026A2 (pt) Modificação química de ácidos gordos maleatados
DK2234994T3 (da) Fedtsyre-butylester-blandinger
EP2120920A4 (en) OXYLIPINES OF LONG-CHAIN MULTIPLE-UNSATURATED FATTY ACIDS AND METHOD FOR THEIR PREPARATION AND USE
EP2459189A4 (en) FATTY ACIDS AS ANTI-INFLAMMATORY AGENTS
BRPI0922486A2 (pt) microcápsulas e suas respectivas utilizações
BRPI0911606A2 (pt) Polipeptídeo e métodos para produzir triacilgliceróis compreendendo ácidos graxos modificados
BRPI1015238A2 (pt) diamidas de azetidilina como inibidores de monoaciglicerol lipase
EP2448431A4 (en) BARRIER COMPOSITIONS AND OVEN-COOKED FOOD ENRICHED WITH OMEGA-3 FATTY ACID
IL215386A0 (en) Algal medium chain length fatty acids and hydrocarbons
EP2306813A4 (en) PEN FOR THE POND ECONOMY
BRPI0819732A2 (pt) produtos de carne com níveis aumentados de ácidos graxos benéficos
BRPI0923438A2 (pt) redução de potência de pico seletiva
BRPI0921959A2 (pt) métodos e composições para remoção de tatuagem
PT2456304E (pt) Métodos de modulação de ácidos de cadeia ramificada e utilização dos mesmos
BRPI0913640A2 (pt) substâncias policrômicas e seus usos
ATE541560T1 (de) Zusammensetzung mit mehrfach ungesättigten fettsäuren und aktivierter holzkohle
DE502009000614D1 (de) Anhängekupplung
EP2285545A4 (en) INJECTION MOLDED ARTICLE AND METHOD FOR MANUFACTURING THE SAME
NO20080778L (no) Kraftelementarrangement og -fremgangsmate
BRPI1012696A2 (pt) composicao nutricional compreendendo curminaoides e metodos de fabricacao
BR112012010510A2 (pt) trator
PL1765318T3 (pl) Średniołańcuchowe kwasy tłuszczowe przydatne jako środki przeciwdrobnoustrojowe

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: PROMETIC PHARMA SMT LIMITED (CA)

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 15A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2747 DE 29-08-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.